What Attendees Say...
"Venture capital is a people business and the NVCA Annual Meeting is a great opportunity for relationship building ."
—Bon French,
Adams Street Partners
"The great speakers and relevant content make us better investors."
—Michael Greeley,
Flybridge Capital Partners
"It's important for our whole team to attend. We learn from meeting up with our peers, how other firms do things differently and how real deals get done."
—Deepak Kamra,
Canaan Partners
"If you don't attend you're missing out."
—Steve Frederick,
Grotech Ventures
"I keep coming year after year because the industry keeps changing. It's a chance to step back from your every day responsibilities and discuss the big issues collectively challenging the venture community."
—Jonathan Leff,
Warburg Pincus
"There is a richer and broader conversation at the NVCA Annual Meeting than at other venture capital industry events"
—Ray Leach,
JumpStart
"It's all about collaboration. You need to be here to meet the right people."
—Jon Callaghan,
True Ventures
|
|
Tuesday, April 24, 2012
|
|
8:30 am - 4:30 pm
|
CFO/In - House Counsel Session
Lunch Sponsored By SRS
|
|
9:00 - 11:30 am
|
Corporate Venture Capital Program
|
|
10:00 - 11:30 am
|
Emerging Managers Program
|
|
11:30 am - 12:30 pm
|
Opening Luncheon
|
|
12:45 - 2:30 pm
|
Opening General Session
Welcome
NVCA Chairman Paul Maeder
Highland Capital Partners
KEYNOTE: Frank Quattrone, Founder & CEO, Qatalyst Partners
Over the past three decades, Frank Quattrone has served as an advisor on more than 400 mergers and acquisitions with an aggregate transaction value of over $500B and on more than 350 financings that raised over $65B for technology companies worldwide. Frank will share his insights and outlook on the venture-backed M&A market and how the new economic reality will change how venture capitalists achieve exits in the future
State of Play in Washington & The Upcoming Presidential Election
NVCA's outgoing Chairman, Paul Maeder (Highland Capital Partners), interviews NVCA President Mark Heesen on the legislative and regulatory issues that promise to have the biggest impact on venture creation, fund management and future investment cycles. Issues to be discussed include tax reform, FDA reform, cleantech issues, online privacy debate and how the Presidential campaign will influence the venture community and innovation economy |
|
2:30 - 2:45 pm
|
Break
|
|
2:45 - 5:15 pm
|
Industry Specific Breakout Sessions
|
|
2:45 - 5:15 pm
|
Technology Track
Battle of the Platforms
The future of software is largely mobile. Entrepreneurs and investors in all markets need to make significant platform decisions as they develop their products and services and evaluate new opportunities. The growth numbers behind Android, and iOS are staggering. Come hear from the leaders behind these platforms and some of the most successful developers working within the mobile ecosystem. Topics to be discussed include: Is this a zero sum game or can there be multiple winners? What new technologies, products and services are in the pipeline? What are the most promising investment opportunities? And, which ones are past their due date?
Rich Miner, Partner, Google Ventures
Andy Miller, General Partner, Highland Capital Partners and Former Apple Executive
Tom Conrad, Chief Technology Officer, Pandora Radio
Melody McCloskey, Founder and CEO, StyleSeat
Steve Jang, Founder and CEO, SoundTracking
**Please check back as more speakers to be announced soon
|
|
2:45 - 5:15 pm
|
Life Sciences Track
FDA’s Role in the Medical Innovation Ecosystem
What steps is FDA taking to advance the development of innovative products and what else can be done?
Janet Woodcock, Director, Center for Drug and Evaluation and Research, FDA
Jeff Shuren, Director, Center for Device and Radiological Health, FDA
Ellen V. Sigal, PhD, Chairperson and Founder of Friends of Cancer Research
Jonathan Leff, General Partner, Warburg Pincus (co-moderator)
Jack Lasersohn, General Partner, The Vertical Group (co-moderator)
The Changing Environment for Demonstrating What Works and What Gets Paid For
The creation of the Patient-Centered Outcomes Research Institute (PCORI) in the new healthcare law accompanies changing evidence expectations for validating drugs and medical technologies and globally. This panel will discuss how PCORI is interacting with such agencies as AHRQ, CMS, FDA, and NIH as well as other public and private-sector organization and resulting implications for medical innovation.
Sean Tunis, MD, Msc, Director, Center for Medical Technology Policy
|
|
2:45 - 5:15 pm
|
Clean Tech Track
Corporate Partnering in Energy Investments
Theodore F. Craver, Jr., Chairman, President and CEO, Edison International
Andrew Shapiro, Former CEO of GreenOrder
**Please check back as more speakers to be announced soon
|
|
5:30 – 8:00 pm
|
Reception and Dinner Buffet
|
|
8:00 – 10:00 pm
|
Dessert and Drinks Reception
Sponsored by TechAssure & Sherwood Partners
|
|
Wednesday, April 25, 2012
|
|
7:15 – 8:00 am
|
Continental Breakfast for members
|
|
8:00 am - 12:15 pm
|
General Session
Opening Remarks and Welcome
Ray Rothrock, Incoming NVCA Chairman, Venrock
Interview with Sue Desmond-Hellman, MD, MPH, Chancellor of the University of California San Francisco (UCSF)
In 2009, Forbes named Dr. Sue Desmond-Hellman one of the world's seven most "powerful innovators." She currently oversees all aspects of UCSF and its highly regarded medical center. Prior to her current role, she was an oncologist, spent more than a decade at Genentech, served on numerous for-profit and not-for-profit Boards. Kerry A. Dolan, Senior Editor with the Silicon Valley Bureau of Forbes will interview this renowned biotechnology leader on the innovations with the most promise to improve all of our lives as well as venture capital investment strategies.
|
|
9:45 – 10:15 am
|
Break
|
|
10:15 - 11:30 am
|
KEYNOTE: Dr. Arun Majumdar, Director ARPA-E, Under Secretary Nominee, Department of Energy
As the first Director of ARPA-E and a former advisor to start-up companies and venture capital firms, Dr. Majumdar has a unique perspective of the clean technologies in development that show the most promise for commercialization and the role that government plays in research and development and technology transfer. Hear his insights regarding how venture capitalists can collaborate with this innovative government agency and the ground breaking technologies that promise to impact the global economy in the future.
|
|
11:30 am – 12:15 pm
|
The New Frontiers of Venture Capital
There has been much discussion during the past year about the rise of the "Super Angel" and if such investors should be viewed as competition, collaborators, or both. On the other end of the spectrum, more and more venture capital firms are engaging in growth equity investing in order to reduce their exit horizons and augment their funds' ROI. What's the overall impact of the ever expanding definition of venture capital and how are venture firms leveraging these trends to their advantage?
Naval Ravikant, co-author of Venture Hacks, and a co-maintainer of AngelList
Mike Maples, Jr., Managing Partner, FLOODGATE
Barry Silbert, Founder & CEO, Second Market
Lise Buyer, Founder, ClassVGroup (moderator)
**Please check back as more speakers to be announced soon
|
|
12:15 pm
|
Closing Buffet Lunch
|
|
|
